title: Recombinant alpha 2 interferon in the treatment of chronic myeloproliferative disorders.
authors.affiliation: Chair of Hematology and Chair of Medical Pathology, Institute of Clinical Medicine, University of Palermo, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Bonaccorso
authors.forename: M
authors.initials: M
authors.lastname: Teresi
authors.forename: V
authors.initials: V
authors.lastname: Gebbia
authors.forename: M
authors.initials: M
authors.lastname: Tambone Reyes
authors.forename: D
authors.initials: D
authors.lastname: Tinnirello
authors.forename: P
authors.initials: P
authors.lastname: Di Marco
authors.forename: P
authors.initials: P
authors.lastname: Citarrella
authors.forename: S
authors.initials: S
authors.lastname: Mansueto
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000097:blood / Q000188:drug therapy*; D010974:Platelet Aggregation / Q000187:drug effects; D055728:Primary Myelofibrosis / Q000188:drug therapy; D011994:Recombinant Proteins; D013920:Thrombocythemia, Essential / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins